HexylHIBO hydrobromide is a potent group I mGluR antagonist with Kbs of 140 µM and 110 µM at mGlu1a and mGlu5a receptors, respectively. HexylHIBO hydrobromide does not inhibits mGlu2 and mGlu4a. HexylHIBO hydrobromide decreases spontaneous excitatory postsynaptic currents (sEPSCs) in rat[1][2].
Molecular Weight:
337.21
Formula:
C12H21BrN2O4
Target:
mGluR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
